Method of selecting DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity

Details for Australian Patent Application No. 2002314629 (hide)

Owner Chromagenics B.V.

Inventors Otte, Arie Pieter; Kruckeberg, Arthur Leo

Agent Davies Collison Cave

Pub. Number AU-B-2002314629

PCT Number PCT/NL02/00390

PCT Pub. Number WO2003/004704

Priority 01202581.3 04.07.01 EP; 60/303,199 05.07.01 US

Filing date 14 June 2002

Wipo publication date 21 January 2003

Acceptance publication date 30 August 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 01202581.3 04.07.01 EP; 60/303,199 05.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002314629

30 August 2007 Application Accepted

  Published as AU-B-2002314629

3 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002314630-SENSOR IN KING-PIN

2002314628-AGONISTIC BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR_